Cargando…
Therapeutic effects of selective p300 histone acetyl-transferase inhibitor on liver fibrosis
Liver fibrosis is caused by chronic liver damage and results in the aberrant accumulation of extracellular matrix during disease progression. Despite the identification of the HAT enzyme p300 as a major factor for liver fibrosis, the development of therapeutic agents targeting the regulation of p300...
Autores principales: | Kim, Hyunsik, Park, Soo-Yeon, Lee, Soo Yeon, Kwon, Jae-Hwan, Byun, Seunghee, Kim, Mi Jeong, Yu, Sungryul, Yoo, Jung-Yoon, Yoon, Ho-Geun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978366/ https://www.ncbi.nlm.nih.gov/pubmed/36593107 http://dx.doi.org/10.5483/BMBRep.2022-0188 |
Ejemplares similares
-
The deubiquitinase UCHL3 mediates p300-dependent chemokine signaling in alveolar type II cells to promote pulmonary fibrosis
por: Lee, Soo Yeon, et al.
Publicado: (2023) -
DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers
por: Li, Shanshan, et al.
Publicado: (2018) -
Proteasomal degradation of the histone acetyl transferase p300 contributes to beta-cell injury in a diabetes environment
por: Ruiz, Lucie, et al.
Publicado: (2018) -
The histone acetyl transferases CBP and p300 regulate stress response pathways in synovial fibroblasts at transcriptional and functional levels
por: Krošel, Monika, et al.
Publicado: (2023) -
Club cell-specific role of programmed cell death 5 in pulmonary fibrosis
por: Park, Soo-Yeon, et al.
Publicado: (2021)